TCM
AGN

Traynor Capital Management’s Allergan plc AGN Stock Holding History

Traynor Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,048
Closed -$200K – 198
2019
Q4 		$200K Buy
+1,048
New +$189K 0.05% 156
2019
Q3 		– Sell
-2,528
Closed -$423K – 185
2019
Q2 		$423K Sell
2,528
-1,055
-29% -$146K 0.14% 96
2019
Q1 		$524K Buy
3,583
+1,071
+43% +$155K 0.18% 86
2018
Q4 		$335K Sell
2,512
-233
-8% -$38.2K 0.14% 99
2018
Q3 		$522K Sell
2,745
-92
-3% -$16.9K 0.17% 85
2018
Q2 		$474K Sell
2,837
-89
-3% -$14.3K 0.17% 88
2018
Q1 		$492K Buy
2,926
+1,189
+68% +$199K 0.2% 81
2017
Q4 		$284K Sell
1,737
-841
-33% -$151K 0.12% 126
2017
Q3 		$526K Buy
2,578
+389
+18% +$90.5K 0.25% 79
2017
Q2 		$554K Buy
2,189
+626
+40% +$147K 0.27% 77
2017
Q1 		$383K Buy
+1,563
New +$364K 0.21% 94

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Traynor Capital Management's AGN Position: Q1 2020 in Review

Traynor Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,048 shares — an estimated $200K sold.

Traynor Capital Management first reported a position in AGN in Q1 2017 and held it in 11 quarters. The position peaked at $554K in Q2 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Traynor Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Traynor Capital Management sold 1,048 Allergan plc shares in Q1 2020, an estimated $200K.
  • Traynor Capital Management first reported a position in Allergan plc in Q1 2017 and held it in 11 quarters.
  • Traynor Capital Management's Allergan plc position peaked at $554K in Q2 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Traynor Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.